Shanghai Henlius Biotech Inc.

01/29/2021 | Press release | Distributed by Public on 01/29/2021 06:00

VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL FOR RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION HLX04-O FOR THE TREATMENT OF WET[...]